The Genetic Bases of Asthma

  • Carlo Selmi
  • Maria De Santis
  • M. Eric Gershwin


Asthma is characterized by acute clinical symptoms such as bronchoconstriction, bronchial inflammation and cough due to increased smooth muscle contractility, epithelial secretion, and tissue remodeling ultimately leading to airway thickening. Numerous genetic, environmental, and hormonal factors underlie the pathological antigen–antibody reaction inducing a vago-vagal axon reflex. The biochemical mechanisms involved in asthma exacerbations include a disequilibrium between two opposite second messenger systems in the airways, favoring the PLC–PKC over the cAMP cascade.


Atopic Dermatitis Allergic Rhinitis Airway Smooth Muscle Cell Candidate Gene Association Study Asthma Susceptibility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Thomsen SF, Kyvik KO, Backer V. A note on twin-singleton differences in asthma. Twin Res Hum Genet. 2008 Apr;11(2):161–4.PubMedCrossRefGoogle Scholar
  2. 2.
    Steinke JW, Borish L. Genetic of allergic disease. Med Clin North Am. 2006;90:1–15.PubMedCrossRefGoogle Scholar
  3. 3.
    Sleiman PAM, Hakonarson H. Recent advances in the genetics and genomics of asthma and related traits. Curr Opin Pediatr. 2010;22:307–12.PubMedCrossRefGoogle Scholar
  4. 4.
    Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol. 2010;105:99–106.PubMedCrossRefGoogle Scholar
  5. 5.
    Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet. 2001;358:1129 –1133.PubMedCrossRefGoogle Scholar
  6. 6.
    Seiskari T, Kondrashova A, Viskari H, et al. Allergic sensitization and microbial load: a comparison between Finland and Russian Karelia. Clin Exp Immunol. 2007;148:47–52.PubMedCrossRefGoogle Scholar
  7. 7.
    von Hertzen L, Laatikainen T, Pitkanen T, et al. Microbial content of drinking water in Finnish and Russian Karelia: implications for atopy prevalence. Allergy. 2007;62:288–292.CrossRefGoogle Scholar
  8. 8.
    Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-offunction variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38:441– 446.PubMedCrossRefGoogle Scholar
  9. 9.
    Kato A, Fukai K, Oiso N, Hosomi N, Murakami T, Ishii M. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol. 2003;148:665–669.PubMedCrossRefGoogle Scholar
  10. 10.
    Miyata M, Hatsushika K, Ando T, et al. Mast cell regulation of epithelial TSLP expression plays an important role in the development of allergic rhinitis. Eur J Immunol. 2008;38:1487–1492.PubMedCrossRefGoogle Scholar
  11. 11.
    Kumar RK, Webb DC, Herbert C, Foster PS. Interferon-gamma as a possible target in chronic asthma. Inflamm Allergy Drug Targets. 2006 Dec;5(4):253–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Chatila TA. Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol Med. 2004 Oct;10(10):493–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Holgate ST. ADAM metallopeptidase domain 33 (ADAM33): identification and role in airways disease. Drug News Perspect. 2010 Jul-Aug;23(6):381–7.PubMedGoogle Scholar
  14. 14.
    Blakey J, Halapi E, Bjornsdottir US, Wheatley A, Kristinsson S, Upmanyu R, Stefansson K, Hakonarson H, Hall IP. Contribution of ADAM33 polymorphisms to the population risk of asthma. Thorax. 2005 Apr;60(4):274–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Laitinen T, Polvi A, Rydman P, Vendelin J, Pulkkinen V, Salmikangas P, Mäkelä S, Rehn M, Pirskanen A, Rautanen A, Zucchelli M, Gullstén H, Leino M, Alenius H, Petäys T, Haahtela T, Laitinen A, Laprise C, Hudson TJ, Laitinen LA, Kere J. Characterization of a common susceptibility locus for asthma-related traits. Science. 2004 Apr 9;304(5668):300–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Yang IA, Fong KM, Holgate ST, Holloway JW. The role of Toll-like receptors and related receptors of the innate immune system in asthma. Curr Opin Allergy Clin Immunol. 2006 Feb;6(1):23–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Duez C, Gosset P, Tonnel AB. Dendritic cells and toll-like receptors in allergy and asthma. Eur J Dermatol. 2006 Jan-Feb;16(1):12–6.PubMedGoogle Scholar
  18. 18.
    Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Blank M, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Levy Y, Orbach H, Pordeus V, Ram M, Sherer Y, Toubi E, Tomer Y. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases – 2008. Isr Med Assoc J. 2008 Jan;10(1):3–7.PubMedGoogle Scholar
  19. 19.
    Weidinger S, Klopp N, Rümmler L, Wagenpfeil S, Baurecht HJ, Gauger A, Darsow U, Jakob T, Novak N, Schäfer T, Heinrich J, Behrendt H, Wichmann HE, Ring J, Illig T; KORA study group. Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adults. Clin Exp Allergy. 2005 Jul;35(7):866–72.PubMedCrossRefGoogle Scholar
  20. 20.
    Mitchell J, Dimov V, Townley RG. IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease. Curr Opin Investig Drugs. 2010 May;11(5):527–34.PubMedGoogle Scholar
  21. 21.
    Basehore MJ, Howard TD, Lange LA, Moore WC, Hawkins GA, Marshik PL, Harkins MS, Meyers DA, Bleecker ER. A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE levels and asthma in white subjects. J Allergy Clin Immunol. 2004 Jul;114(1):80–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Battle NC, Choudhry S, Tsai HJ, Eng C, Kumar G, Beckman KB, Naqvi M, Meade K, Watson HG, Lenoir M, Burchard EG; SAGE Investigators. Ethnicity-specific gene-gene interaction between IL-13 and IL-4Ralpha among African Americans with asthma. Am J Respir Crit Care Med. 2007 May 1;175(9):881–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Zhang Y, Zhang J, Huang J, Li X, He C, Tian C, Peng C, Guo L, Xiao Y, Fan H. Polymorphisms in the transforming growth factor-beta1 gene and the risk of asthma: A meta-analysis. Respirology. 2010 May;15(4):643–50.PubMedCrossRefGoogle Scholar
  24. 24.
    Hizawa N. Beta-2 adrenergic receptor genetic polymorphisms and asthma. J Clin Pharm Ther. 2009 Dec;34(6):631–43.PubMedCrossRefGoogle Scholar
  25. 25.
    Minelli C, Granell R, Newson R, Rose-Zerilli MJ, Torrent M, Ring SM, Holloway JW, Shaheen SO, Henderson JA.. Glutathione-S-transferase genes and asthma phenotypes: a Human Genome Epidemiology (HuGE) systematic review and meta-analysis including unpublished data. Int J Epidemiol. 2010 Apr;39(2):539–62.PubMedCrossRefGoogle Scholar
  26. 26.
    Liu Q, Xia Y, Zhang W, Li J, Wang P, Li H, Wei C, Gong Y. A functional polymorphism in the SPINK5 gene is associated with asthma in a Chinese Han Population. BMC Med Genet. 2009 Jun 17;10:59.PubMedCrossRefGoogle Scholar
  27. 27.
    Moffatt M, Kabesch M, Liang L, Dixon AL, Strachan D, Heath S, Depner M, von Berg A, Bufe A, Rietschel E, Heinzmann A, Simma B, Frischer T, Willis-Owen SA, Wong KC, Illig T, Vogelberg C, Weiland SK, von Mutius E, Abecasis GR, Farrall M, Gut IG, Lathrop GM, Cookson WO. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature. 2007;448:470–3.PubMedCrossRefGoogle Scholar
  28. 28.
    Himes BE, Hunninghake GM, Baurley JW, Rafaels NM, Sleiman P, Strachan DP, Wilk JB, Willis-Owen SA, Klanderman B, Lasky-Su J, Lazarus R, Murphy AJ, Soto-Quiros ME, Avila L, Beaty T, Mathias RA, Ruczinski I, Barnes KC, Celedón JC, Cookson WO, Gauderman WJ, Gilliland FD, Hakonarson H, Lange C, Moffatt MF, O’Connor GT, Raby BA, Silverman EK, Weiss ST. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet. 2009:84:581–93.PubMedCrossRefGoogle Scholar
  29. 29.
    Sleiman PM, Flory J, Imielinski M, Bradfield JP, Annaiah K, Willis-Owen SA, Wang K, Rafaels NM, Michel S, Bonnelykke K, Zhang H, Kim CE, Frackelton EC, Glessner JT, Hou C, Otieno FG, Santa E, Thomas K, Smith RM, Glaberson WR, Garris M, Chiavacci RM, Beaty TH, Ruczinski I, Orange JM, Allen J, Spergel JM, Grundmeier R, Mathias RA, Christie JD, von Mutius E, Cookson WO, Kabesch M, Moffatt MF, Grunstein MM, Barnes KC, Devoto M, Magnusson M, Li H, Grant SF, Bisgaard H, Hakonarson H.. Variants of DENND1B associated with asthma in children. N Engl J Med. 2010;362:36–44.PubMedCrossRefGoogle Scholar
  30. 30.
    Mathias RA, Grant AV, Rafaeles N, Hand T, Gao L, Vergara C, Tsai YJ, Yang M, Campbell M, Foster C, Gao P, Togias A, Hansel NN, Diette G, Adkinson NF, Liu MC, Faruque M, Dunston GM, Watson HR, Bracken MB, Hoh J, Maul P, Maul T, Jedlicka AE, Murray T, Hetmanski JB, Ashworth R, Ongaco CM, Hetrick KN, Doheny KF, Pugh EW, Rotimi CN, Ford J, Eng C, Burchard EG, Sleiman PM, Hakonarson H, Forno E, Raby BA, Weiss ST, Scott AF, Kabesch M, Liang L, Abecasis G, Moffatt MF, Cookson WO, Ruczinski I, Beaty TH, Barnes KC. A genome-wide association study on African-ancestry populations for asthma. J Allergy Clin Immunol. 2010 Feb;125(2):336–346.PubMedCrossRefGoogle Scholar
  31. 31.
    Barnes P. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009;6:693–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, Barnes PJ. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med. 2005 May 12;352(19):1967–76.PubMedCrossRefGoogle Scholar
  33. 33.
    Kagoshima M, Wilcke T, Ito K, Tsaprouni L, Barnes PJ, Punchard N, Adcock IM. Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation. Eur J Pharmacol. 2001 Oct 19;429(1-3):327–34.PubMedCrossRefGoogle Scholar
  34. 34.
    Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8921–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Carlo Selmi
    • 1
    • 2
  • Maria De Santis
    • 3
  • M. Eric Gershwin
    • 1
  1. 1.Division of Rheumatology, Allergy and Clinical Immunology, Department of Internal MedicineUniversity of California at DavisDavisUSA
  2. 2.Autoimmunity and Metabolism Unit, Department of MedicineIRCCS Istituto Clinico HumanitasMilanItaly
  3. 3.Clinica Medica, Studio Medici ESTIRCCS Istituto Clinico HumanitasMilanItaly

Personalised recommendations